These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35992814)

  • 21. Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma.
    Zhang C; Wang K; Liu W; Lin J; Li Z; Wang H; Zhao C; Chen Y; Wu S; Yang A; Wu J; Wang H
    Front Oncol; 2022; 12():1054845. PubMed ID: 36591517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An
    Ruan X; Ye Y; Cheng W; Xu L; Huang M; Chen Y; Zhu J; Lu X; Yan F
    Front Med (Lausanne); 2022; 9():894338. PubMed ID: 35721082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
    Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
    Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.
    Choi S; Kim HR; Sung CO; Kim J; Kim S; Ahn SM; Choi CM; Chun SM; Choi EK; Kim SW; Kim YH; Lee JY; Song JS; Kim D; Haq F; Lee SY; Lee JE; Jung WR; Jang HY; Yang E; Lee C; Yu E; Kong G; Baek D; Jang SJ
    Clin Cancer Res; 2015 Jun; 21(11):2613-23. PubMed ID: 25294902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern.
    Li Y; Chen D; Xu Y; Ding Q; Xu X; Li Y; Mi Y; Chen Y
    J Clin Pathol; 2024 Aug; ():. PubMed ID: 39097406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas.
    Lee MC; Buitrago DH; Kadota K; Jones DR; Adusumilli PS
    Lung Cancer Manag; 2014 Jun; 3(3):245-253. PubMed ID: 25202339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.
    Katsumata S; Aokage K; Miyoshi T; Tane K; Nakamura H; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Hayashi R; Tsuboi M; Ishii G
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1679-1688.e2. PubMed ID: 30257286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma.
    Wang L; Song Y; Bai J; Sun W; Yu J; Cai M; Fu S
    Front Genet; 2022; 13():924781. PubMed ID: 35860464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
    Xu Y; Zhu C; Qian W; Zheng M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Wen Y; Lin A; Zhu W; Wei T; Luo P; Guo L; Zhang J
    Front Pharmacol; 2021; 12():645862. PubMed ID: 34163353
    [No Abstract]   [Full Text] [Related]  

  • 36. The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.
    Zhang H; Huang W; Liu C; Giaccone G; Zhao X; Sun X; Li J; Cheng R; Huang Q; Mo H; Zhang Z; Zhang B; Wang C
    Front Oncol; 2021; 11():657506. PubMed ID: 34026636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
    Zhang S; Zeng X; Lin S; Liang M; Huang H
    J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
    Tomonaga N; Nakamura Y; Yamaguchi H; Ikeda T; Mizoguchi K; Motoshima K; Doi S; Nakatomi K; Iida T; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2013 Sep; 14(5):521-6. PubMed ID: 23786997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic Significance of Cigarette Smoking in Association with Histologic Subtypes of Resected Lung Adenocarcinoma.
    Yi JH; Choi PJ; Jeong SS; Bang JH; Jeong JH; Cho JH
    Korean J Thorac Cardiovasc Surg; 2019 Oct; 52(5):342-352. PubMed ID: 31624712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.